Tuberculous lymphadenitis in Manitoba: Incidence, clinical characteristics and treatment

Canadian Respiratory Journal

Volumn 11, Issue 4, 2004, Pages 279-286

  Cook, Victoria J ^a,b   Manfreda, Jure ^a   Hershfield, Earl S ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

Extrapulmonary tuberculosis; Scrofula; Tuberculous lymphadenitis

Indexed keywords

CAPREOMYCIN; CIPROFLOXACIN; CLOFAZIMINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; PYRAZINAMIDE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ATYPICAL MYCOBACTERIOSIS; AWARENESS; CALCULATION; CANADA; CERVICAL LYMPH NODE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CULTURAL FACTOR; DRUG SENSITIVITY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTCOMES RESEARCH; PACIFIC ISLANDS; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; RELAPSE; RETROSPECTIVE STUDY; REVIEW; SEX DIFFERENCE; SYSTEMATIC REVIEW; TUBERCULOUS LYMPHADENITIS;

EID: 4143061658     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/826501     Document Type: Review

References (42)

1. World Health Organization. Information Fact Sheet No. 104; Tuberculosis (Revised March 2004) (Version current at May 20, 2004).
2. World Health Organization. Global Tuberculosis Control Annual Report (2001) (Version current at May 20, 2004).
3. Health Canada. Annual Reports Tuberculosis in Canada. (1996-2001) (Version current at May 26, 2004).
4. Annual Reports of the Sanatorium Board of Manitoba, 1990-2000.
5. Artenstein AW, Kim JH, Williams WJ, Chung RC. Isolated peripheral tuberculous lymphadenitis in adults: current clinical and diagnostic issues. Clin Infect Dis 1995;20:876-82.
6. Enarson DA, Ashley MJ, Gryzybowski S, Ostapkowicz E, Dorken E. Non-respiratory tuberculosis in Canada. Epidemiologic and bacteriologic features. Am J Epidemiol 1980;112:341-51.
7. Fanning A. Extrapulmonary Tuberculosis. CMAJ 1999; 160:1597-1603.
8. Chen TM, Lee PY, Perng RP Extrapulmonary tuberculosis: Experience at Veterans General Hospital-Taipei, 1985 to 1987. J Formos Med Assoc 1991;90:1163-70.
9. Saraiya M, Binkin NJ. Tuberculosis Among Immigrants. In: Reichman LB, Hershfield ES. Tuberculosis: A comprehensive international approach. Lung Biology in Health and Disease; Volume 66. New York: Marcel Dekker Inc., 1993:661-92.
10. Grange J, Collins C, Yates M. Bacteriological survey of tuberculous lymphadenitis in southeast England, 1973-1980. J Epidemiol Community Health 1982;36:157-61.
11. Njoo H, Long R. The Epidemiology of Tuberculosis in Canada. In: Long R. Canadian Tuberculosis Standards. 5th edn. 2000:3-14.
12. Kent PT, Kubica GP. Public Health Mycobacteriology: A Guide for the Level III Laboratory, 1985.
13. Grange JM, Yates MD, de Kantor IN. Guidelines for speciation within the Mycobacterium tuberculosis complex. Second Edition. (Version current at May, 2004).
14. American Thoracic Society. Treatment of Tuberculosis and Tuberculosis Infection in Adults and Children. Am J Respir Crit Care Med 1993;149:S1-25.
15. McCarthy OR, Rudd RM. Six months chemotherapy for lymph node tuberculosis. Respir Med 1989;83:425-7.
16. Campbell IA, Omerod LF. Six month versus nine months chemotherapy for tuberculosis of the lymph nodes: Final Results. Respir Med 1993;87:621-3.
17. Jawahar MS. Scrofula revisited: An update on the diagnosis and management of tuberculosis of superficial lymph nodes. Indian J Pediatr 2000;67(Suppl 2):S28-33.
18. Menzies D, Pourier L. Diagnosis of Tuberculosis Infection and Disease. In: Long R. Canadian Tuberculosis Standards. 5th edn. Ottawa, Ontario: Health Canada, 2000:45-66.
19. Tomblin JL, Roberts FJ. Tuberculous cervical lymphadenitis. CMAJ 1979;121:324-30.
20. Manolidis S, Frenkiel S, Yoskovitch A, Black M. Mycobacterial infections of the head and neck. Otolaryngol Head Neck Surg 1993;109(3Pt1):427-33.
21. Martin T, Hoeppner VH, Ring ED. Superficial mycobacterial lymphadenitis in Saskatchewan. CMAJ 1998;138:431-4.
22. Cowie RL, Sharpe JW. Extra-pulmonary tuberculosis: a high frequency in the absence of HIV infection. Int J Tuberc Lung Dis 1997;1:159-62.
23. Grzybowski S, Allen EA. History and importance of scrofula. Lancet 1995;346:1472-4.
24. Geldmacher H, Taube C, Kroeger C, Magnussen H, Kirsten, DK. Assessment of lymph node tuberculosis in Northern Germany. Chest 2002;121:1177-82.
25. Sloane MF. Mycobacterial Lymphadenitis. In: Rom WN, Garay SM. Tuberculosis. Boston: Little, Brown and Company (Inc), 1996:577-84.
26. Chen YM, Lee PY, Su WJ, Perng RP. Lymph node tuberculosis: 7-year experience in Veterans General Hospital, Taipei, Taiwan. Tuber Lung Dis 1992;73:368-71.
27. Pang SC. Mycobacterial lymphadenitis in Western Australia. Tuber Lung Dis 1992;73:362-7.
28. Wilkins EG, Roberts C. Superficial tuberculous lymphadenitis in Merseyside: 1969-1984. J Hyg (Lond) 1985;95:115-22.
29. Summers GD, McNicol MW. Tuberculosis of superficial lymph nodes. Br J Dis Chest 1980;74:369-73.
30. Qazi SA, Khan S, Khan MA. Epidemiology of childhood tuberculosis in a hospital setting. J Pak Med Assoc 1998;48:164-7.
31. Set V, Kabra SK, Jain Y, Semwal OP, Mukhopadhyaya S, Jensen R. Tubercular lymphadenitis: Clinical manifestations. Indian J Pediatr 1995;62:565-70.
32. Memish ZA, Mah MW, Mahmood SA, Bannatyne RM, Khan MY. Clinico-diagnostic experience with tuberculous lymphadenitis in Saudi Arabia. Clin Microbiol Infect 2000;6:137-41.
33. Grigg ERN. The arcana of tuberculosis. Am Rev Tuberc 1958;78:151-72.
34. Wark P, Goldberg H, Ferson M, McKenzie D, Lau E, Rivas K. Mycobacterial lymphadenitis in eastern Sydney. Aust N Z J Med 1998;28:453-8.
35. Yates MD, Grange JM. Bacteriological survey of tuberculous lymphadenitis in southeast England, 1981-1989. J Epidemiol Community Health 1992;46:332-5.
36. Dankner WM, Davis CE. Mycobacterium bovis as a significant cause of tuberculosis in children residing along the United States-Mexico Border in the Baja California region. Pediatrics 2000;105:1-5.
37. Dankner WM, Waecker NJ, Essey MA, et al. Mycobacterium bovis infections in San Diego: A clinicoepidemiologic study of 73 patients and a historical review of a forgotten pathogen. Medicine 1993;72:11-37.
38. Kazwala RR, Daborn CJ, Sharp JM, et al. Isolation of Mycobacterium bovis form human cases of cervical adenitis in Tanzania: A cause for concern? Int J Tuberc Lung Dis 2001;5:87-91.
39. Omerud LP, Bentley C. The management of lymph node tuberculosis notified in England and Wales in 1993. J R Col Physicians Lond 1997;31:666-8.
40. Xie HJ, Enarson DA, Chao CW, Allen EA, Grzybowski S. Deaths in tuberculosis patients in British Columbia, 1980-1984. Tuber Lung Dis 1992;73:77-82.
41. Shriner KA, Mathisen GE, Goetz MB. Comparison of mycobacterial lymphadenitis among persons infected with human immunodeficiency virus and seronegative controls. Clin Infect Dis 1992;15:601-15.
42. Bem C. Human immunodeficiency virus-positive tuberculous lymphadenitis in Central Africa: clinical presentation of 157 cases. Int J Tuberc Lung Dis 1997;1:215-9.